Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,204 | 42,988 | 28,847 | 29,474 | 23,254 |
| Marketable Securities | 15 | 15 | 17 | 8,530 | 12,028 |
| Receivables | 36,007 | 33,755 | 25,934 | 31,677 | 30,036 |
| Inventories | 12,584 | 11,719 | 14,272 | 14,810 | 13,115 |
| TOTAL | $83,100 | $91,266 | $72,577 | $89,152 | $83,115 |
| Non-Current Assets | |||||
| PPE Net | 568 | 616 | 528 | 572 | 477 |
| Intangibles | 67,143 | 68,744 | 70,043 | 71,644 | 82,388 |
| Other Non-Current Assets | 6,381 | 7,341 | 23,901 | 19,820 | 20,356 |
| TOTAL | $74,092 | $76,701 | $94,472 | $92,036 | $103,221 |
| Total Assets | $157,192 | $167,967 | $167,049 | $181,188 | $186,336 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 113,859 | 85,506 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 15,721 | 20,002 | 16,929 | 28,245 | 30,976 |
| Accrued Expenses | 21,199 | 20,212 | 24,151 | 20,896 | 20,587 |
| Other current liabilities | 41,785 | 39,223 | 31,390 | 30,711 | 28,356 |
| TOTAL | $193,530 | $166,415 | $73,901 | $81,470 | $81,662 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 86,397 | 83,620 | 83,516 |
| Other Non-Current Liabilities | 9,689 | 13,492 | 11,994 | 7,223 | 9,609 |
| TOTAL | $9,689 | $13,492 | $98,391 | $90,843 | $93,125 |
| Total Liabilities | $203,219 | $179,907 | $172,292 | $172,313 | $174,787 |
| Shareholders' Equity | |||||
| Common Shares | 1,834 | 1,827 | 1,506 | 1,495 | 1,316 |
| Retained earnings | -431,268 | -397,181 | -382,697 | -367,866 | -345,368 |
| TOTAL | $-46,027 | $-11,940 | $-5,243 | $8,875 | $11,549 |
| Total Liabilities And Equity | $157,192 | $167,967 | $167,049 | $181,188 | $186,336 |